DISSOCIATION BETWEEN THE ANTI-AGGREGATORY & ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN αIIbβ3 (GPIIb/IIIa) ANTAGONISTS, c7E3 AND DMP728

This publication has 23 references indexed in Scilit:

• New Antiplatelet Agents: Platelet GPIIb/llla Antagonists
  Thrombosis and Haemostasis, 1995
• Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
  Circulation, 1994
• Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets
  Thrombosis Research, 1993
• Antiplatelet Efficacy and Specificity of DMP728, a Novel Platelet GPIIb/llla Receptor Antagonist
  Cardiology, 1993
• Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets
  Nature, 1992
• Inhibition of platelet activation by tyrosine kinase inhibitors
  Biochemical Pharmacology, 1992
• Antiplatelet Agents in the Prevention and Therapy of Thrombosis
  Annual Review of Medicine, 1992
• GPIIb-IIIa: The responsive integrin
  Cell, 1991
• Molecular mechanisms of platelet activation.
  Physiological Reviews, 1989
• The action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin
  Biochemical Journal, 1988